Last Updated on April 21, 2023 by The Health Master
The Department of Pharmaceuticals (DoP) has set up a committee to oversee the implementation of the production-linked incentive (PLI) scheme for pharmaceuticals.
The committee will be headed by the Secretary of the Department and will be responsible for selecting applicants and regularly monitoring the scheme’s progress.
To facilitate the committee’s work, the Department has issued an amendment to the operational guidelines of the Scheme, creating the Scheme Selection and Steering Committee (SSSC).
The SSSC will work in conjunction with the Empowered Group of Secretaries (EGoS), which is already tasked with monitoring the scheme.
The SSSC will be responsible for selecting applicants for the scheme and monitoring its progress.
The committee will be chaired by the Secretary of the DoP and will comprise the additional secretary and financial advisor, joint secretary (Policy), joint secretary (NIPER), and the deputy secretary or director (policy), with DoP.
The deputy secretary or director (Scheme), DoP, will be the convenor of the committee. The committee may also co-opt Drugs Controller General (India) or other officials as special invitees on an as-needed basis.
The committee will meet at least once a quarter to review and monitor the implementation of the Scheme.
The PLI scheme for pharmaceuticals was launched under the Atmanirbhar Bharat initiative of the Indian government in 2021, with a financial outlay of Rs. 15,000 crore over six years. The scheme aims to bring in investments of over Rs. 17,000 crore in the pharmaceutical sector.
So far, 55 applicants have been selected under the scheme, including 20 micro, small & medium enterprises (MSMEs).
In February, the Department released the first tranche of incentives under the product-linked incentive scheme of pharmaceuticals amounting to Rs. 166 crore to four selected applicants.
The scheme covers a range of product categories from cell and gene therapy to phyto-pharmaceuticals, with the potential to generate 20,000 direct and 80,000 indirect jobs, as well as increase the value addition in exports.
The DoP has earmarked Rs. 690 crore as the budget outlay for the financial year 2022-2023, which is the first year of production for the PLI scheme. The scheme is estimated to generate incremental sales of Rs. 2,94,000 crore during six years from FY 2022-23 to 2027-28.
Highlights
- The Department of Pharmaceuticals (DoP) in India has set up a committee called the Scheme Selection and Steering Committee (SSSC) to select applicants and monitor the progress of the production linked incentive (PLI) scheme for pharmaceuticals.
- The committee is headed by the Secretary of the Department and includes other members from the DoP and may co-opt other officials on a need basis.
- The PLI scheme is part of the Atmanirbhar Bharat initiative and has a financial outlay of Rs. 15,000 crore over a period of six years.
- So far, 55 applicants have been selected, including 20 micro, small & medium enterprises (MSMEs).
- The scheme is expected to bring in investment of more than Rs. 17,000 crore in the pharmaceutical sector.
- The support under PLI schemes is expected to promote the production of high-value products in the country and increase the value addition in exports.
- It is also expected to generate employment for both skilled and unskilled personnel, estimated at 20,000 direct and 80,000 indirect jobs as a result of growth in the sector.
- Total incremental sales of Rs. 2,94,000 crore are estimated during six years from FY 2022-23 to 2027-28.
USFDA gives approval for generic Rocuronium Bromide Injection
Difference: Disintegration and Dissolution test in pharma industry
USFDA gives approval for Prochlorperazine Maleate Tablets USP
New study on the effectiveness of Homoeopathy Medicines
PCI to extend approval for existing Pharmacy Courses
No link between antacid Ranitidine and cancer risk: Study
How to prepare SOPs in the Pharma Industry
NMC rejects proposal to allow Pharmacists to write Prescriptions
Difference between branded and generic medicines
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
